Flu vaccine patch shows promise in early safety trial
NCT ID NCT06417853
First seen Mar 28, 2026 · Last updated May 14, 2026 · Updated 8 times
Summary
This early-stage study tested a new vaccine against H7N9 bird flu, given through a small skin patch instead of a needle. It involved 267 healthy adults aged 18 to 50. The main goal was to check if the vaccine is safe and tolerable, while also measuring the body's immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for H7N9 INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Doherty Clinical Trials Ltd
East Melbourne, Victoria, 3002, Australia
-
University of Sunshine Coast Clinical Trials
Morayfield, Queensland, 4506, Australia
-
University of Sunshine Coast Clinical Trials
Sippy Downs, Queensland, 4556, Australia
-
University of Sunshine Coast Clinical Trials
South Brisbane, Queensland, 4101, Australia
Conditions
Explore the condition pages connected to this study.